A novel angiogenesis model for screening anti-angiogenic compounds: The chorioallantoic membrane/feather bud assay

International Journal of Oncology

Volumn 37, Issue 1, 2010, Pages 71-79

  Chen, Haiming ^a   Wang, Cathy S ^a   Li, Mingjie ^a   Sanchez, Eric ^a   Li, Jennifer ^a   Berenson, Ariana ^a   Wirtschafter, Eric ^a   Wang, James ^a   Shen, Shen ^a   Li, Zhiwei ^a   Bonavida, Benjamin ^b   Berenson, James R ^a  

^a INSTITUTE FOR MYELOMA AND BONE CANCER RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Chorioallantoic membrane; Feather bud assay

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; FUMAGILLIN; MINOCYCLINE; SARCOLYSIN; ZOLEDRONIC ACID; ANGIOGENESIS INHIBITOR; CYCLOHEXANE DERIVATIVE; MELPHALAN; SESQUITERPENE; UNSATURATED FATTY ACID;

ACCURACY; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL; CHORIOALLANTOIS; DRUG SCREENING; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BIOASSAY; BIOLOGICAL MODEL; CELL CULTURE; CHICK EMBRYO; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; EMBRYOLOGY; EVALUATION STUDY; FEATHER; ISOLATION AND PURIFICATION; LIMB BUD; PHYSIOLOGY; PROCEDURES; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BIOLOGICAL ASSAY; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CYCLOHEXANES; DRUG SCREENING ASSAYS, ANTITUMOR; FATTY ACIDS, UNSATURATED; FEATHERS; LIMB BUDS; MELPHALAN; MINOCYCLINE; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; SESQUITERPENES;

EID: 77953219207     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000654     Document Type: Article

References (40)

1. Folkman J: Angiogenesis. Annu Rev Med 57: 1-18, 2006.
2. Andreoli CM and Miller JW: Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18: 502-508, 2007. (Pubitemid 351339405)
3. Makale M: Noninvasive imaging of blood vessels. Methods Enzymology: Chapter 8, 444: 175-199, 2008.
4. Hanna E, Quick J and Libutti S: The tumour microenvironment: a novel target for cancer therapy. Oral Dis 15: 8-17, 2009.
5. Sachdev JC and Jahanzeb M: Evolution of bevacizumab-based therapy in the management of breast cancer. Clin Breast Cancer 8: 402-410, 2008.
6. Lakka SS and Rao JS: Antiangiogenic therapy in brain tumors. Expert Rev Neurother 8: 1457-1473, 2008.
7. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342, 2004.
8. Miller K, Wang M, Gralow J, et al: Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 357: 2666-2676, 2007.
9. Chen H, Campbell RA, Chang Y, et al: Tumor-produced pleiotrophin induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis. Blood 113: 1992-2002, 2009.
10. Brown KJ, Maynes SF, Bezos A, Maguire DJ, Ford MD and Parish CR: A novel in vitro assay for human angiogenesis. Lab Invest 75: 539-555, 1996.
11. Frater-Schroder M, Risau W, Hallmann R, Gautschi P and Bohlen P: Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84: 5277-5281, 1987.
12. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J and Dvorak AM: Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57: 673-686, 1987.
13. Montesano R, Orci L and Vassalli P: In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 97: 1648-1652, 1983.
14. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR and Kleinman HK: Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58: 933-943, 1989.
15. Friedlander M, Brooks PC, Shaffer RW and Kincaid CM: Definition of two angiogenic pathways by distinct alpha v integrins. Science 270: 1500-1502, 1995. (Pubitemid 3005294)
16. Chen C, Parangi S, Tolentino MJ and Folkman J: A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res 55: 4230-4233, 1995.
17. Miller JW, Adamis AP, Shima DT, et al: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145: 574-584, 1994.
18. Brooks PC, Strömblad S, Klemke R, Visscher D, Sarkar FH and Cheresh DA: Anti-integrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96: 1815-1822, 1995.
19. Passaniti A, Taylor RM, Pili R, et al: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67: 519-528, 1992.
20. Ribatti D, Vacca A, Roncali L and Dammacco F: The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol 1: 73-82, 2000.
21. Brooks PC, Clark RA and Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569-571, 1994.
22. Nguyen M, Shing Y and Folkman J: Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47: 31-40, 1994. (Pubitemid 24194854)
23. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H and Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-557, 1990. (Pubitemid 120015110)
24. Passaniti A: Extracellular matrix-cell interactions: Matrigel and complex cellular pattern formation. Lab Invest 67: 804-808, 1992.
25. Yao JS, Chen Y, Zhai W, Xu K, Young WL and Yang GY: Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 95: 364-371, 2004.
26. Soltau J, Zirrgiebel U, Esser N, et al: Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model. Anticancer Res 28: 933-941, 2008.
27. Scavelli C, Di Pietro G, Cirulli T, et al: Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma. Mol Cancer Ther 6: 3256-3262, 2007.
28. Lee K, Qian DZ, Rey S, Wei H and Liu JO: Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc Natl Acad Sci USA 106: 2353-2358, 2009.
29. Zhang J, Sattler M, Tonon G, et al: Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1α-dependent pathway in multiple myeloma. Cancer Res 69: 5082-5090, 2009.
30. Risau W and Flamme I: Vasculogenesis. Annu Rev Cell Dev Biol 11: 73-91, 1995.
31. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000.
32. Risau W: Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
33. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
34. Shi Q, Rafii S, Wu MH, et al: Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367, 1998.
35. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K and Mittal V: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198, 2008.
36. Rehman J, Li J, Orschell CM and March KL: Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003.
37. Bailey AS, Willenbring H, Jiang S, et al: Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA 103: 13156-13161, 2006. (Pubitemid 44338932)
38. Conejo-Garcia JR, Benencia F, Courreges MC, et al: Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of VEGF-A. Nat Med 10: 950-958, 2004.
39. Vernon RB and Sage EH: Between molecules and morphology. Extracellular matrix and creation of vascular form. Am J Pathol 147: 873-883, 1995.
40. Vernon RB and Sage EH: A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc Res 57: 118-133, 1999.